UNSPSC 85642187: Supplement of left upper arm subcutaneous tissue and fascia with nonautologous tissue substitute, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement of left upper arm subcutaneous tissue and fascia with nonautologous tissue substitute, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0JUF3KZ

UNSPSC 85642187 Supplement of left upper arm subcutaneous tissue and fascia with nonautologous tissue substitute, percutaneous approach is a Commodity code that shows little relevant recent state and local procurement activity. The code nominally describes a specific surgical procedure involving soft-tissue augmentation of the upper arm, but the recent state and local opportunities tagged under it encompass occupational medical surveillance, disability benefits medical record review, pharmacy benefit management, temporary health professional staffing, surgical procedure carve-out networks, and youth detention healthcare services — none of which involve upper-arm tissue supplementation or the procurement of related surgical supplies, implants, or devices. The mismatch between the code's clinical descriptor and the work actually being solicited suggests either a classification error in the state and local posting systems or a fundamental misalignment between the UNSPSC taxonomy as applied to healthcare administration and the clinical services state and local health systems actually buy.

The recent opportunities attributed to this code reflect healthcare service administration and network management across multiple state and local issuing bodies, including the City of Phoenix Retirement Office, City of Long Beach, Washington State Department of Transportation, Harris County Juvenile Probation Department, Collier County Health Services, and County of Santa Clara Health System, spanning Arizona, California, Washington, Texas, and Florida. Response dates range from September 25, 2026 through April 9, 2026, with contract values from $750,000 over five years (Phoenix independent medical evaluations) to approximately $8.7 million annually (Collier County pharmacy benefit management). Because the code does not reflect a coherent procurement category for surgical-supply or implant vendors, no credible market-development opportunity exists under this code designation. Vendors pursuing tissue-supplement products or services should verify their transactions against higher-order UNSPSC family and segment codes before relying on this commodity code for lead generation or historical-opportunity analysis.